Journal
TAIWAN JOURNAL OF OPHTHALMOLOGY
Volume 10, Issue 1, Pages 3-12Publisher
WOLTERS KLUWER MEDKNOW PUBLICATIONS
DOI: 10.4103/tjo.tjo_4_20
Keywords
Amniotic membrane; ophthalmology; umbilical cord
Categories
Funding
- National Eye Institute, National Institutes of Health, Bethesda MD, USA [RO1 EY06819]
Ask authors/readers for more resources
The birth tissue is predominantly comprised of amniotic membrane (AM) and umbilical cord (UC), which share the same cell origin as the fetus. These versatile biological tissues have been used to treat a wide range of conjunctival and corneal conditions since 1940. The therapeutic benefits of the birth tissue stem from its anti-inflammatory and anti-scarring properties that orchestrate regenerative healing. Although the birth tissue also contains many cytokines, growth factors, and proteins, the heavy chain 1-hyaluronic acid/pentraxin 3 (HC-HA/PTX3) matrix has been identified to be a major active tissue component responsible for AM/UC's multifactorial therapeutic actions. HC-HA/PTX3 complex is abundantly present in fresh and cryopreserved AM/UC, but not in dehydrated tissue. In this review, we discuss the tissue anatomy, the molecular mechanism of action based on HC-HA/PTX3 to explain their therapeutic potentials, and the various forms available in ophthalmology.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available